Results 121 to 130 of about 13,126,675 (165)

Efficacy of Liposomal Amphotericin B in Treating Pulmonary <i>Aspergillus flavus</i> Infection in Nonneutropenic Adults: Cases Report and Literature Review. [PDF]

Clin Case Rep
Chen X, Wang L, Li J, Zhang Y, Liu C, Yang J, Shi J, Liang S.   +7 more
europepmc   +1 more source

Comparative effectiveness of echinocandins and liposomal amphotericin B for fluconazole-resistant <i>Candida parapsilosis</i> bloodstream infections. [PDF]

Antimicrob Agents Chemother
Vena A, Bartalucci C, Muccio M, Tiseo G, Muñoz P, Cesaretti M, Di Pilato V, Marchese A, Barbieri R, Forniti A, Giacobbe DR, Limongelli A, Lupetti A, Mikulska M, Salmanton-García J, Soriano Martín A, Taramasso L, Valerio M, Escribano P, Guinea J, Bouza E, Falcone M, Bassetti M, ESCMID Fungal Infection Study Group (EFISG).   +23 more
europepmc   +1 more source

Recidivans cutaneous leishmaniasis unresponsive to liposomal amphotericin B (AmBisome®)

A 60-year-old woman with thick crusted erythematous plaques on her glabella, apex nasi and left infraorbital region was diagnosed as recidivans cutaneous leishmaniasis. The lesions were resistant to antimonial drugs.
Afsar, S, Gündüz, K, Türel, A, Filiz, EE, Kandiloglu, AR, Ok, ÜZ, Ayhan, S   +6 more
core  

Bidirectional Interaction Between Liposomal Amphotericin B Pharmacokinetics and Parasite Dynamics in Patients With Post-Kala-Azar Dermal Leishmaniasis: Potential Implications for Optimal Dosing. [PDF]

Clin Pharmacol Ther
Chu WY, Singh OP, Sundar S, Mondal D, Pandey K, Das P, Roseboom IC, Raja S, Torres A, Carrillo E, Huitema ADR, Alves F, Dorlo TPC.   +12 more
europepmc   +1 more source

In Vitro Evaluation of Liposomal Amphotericin B Adsorption With Different Hemofilters for Continuous Hemofiltration. [PDF]

Artif Organs
Hiraiwa T, Kuriyama N, Moriyama K, Yamada S, Nakamura T, Nishida O.   +5 more
europepmc   +1 more source

Single-dose liposomal amphotericin B for visceral leishmaniasis

The Lancet Global Health, 2014
Nilima A Kshirsagar
doaj   +1 more source

Comparative study of liposomal amphotericin B, posaconazole, and micafungin for primary antifungal prophylaxis in pediatric patients with acute leukemia. [PDF]

J Cancer Res Clin Oncol
Gottschlich AS, Ernst J, Milde T, Gruhn B.   +3 more
europepmc   +1 more source

Role of liposomal amphotericin B in intensive care unit: an expert opinion paper. [PDF]

J Anesth Analg Crit Care
Bussini L, Bartoletti M, Bassetti M, Cortegiani A, De Pascale G, De Rosa FG, Falcone M, Giannella M, Girardis M, Grossi P, Mikulska M, Navalesi P, Pea F, Sanguinetti M, Tascini C, Viaggi B, Viale P.   +16 more
europepmc   +1 more source

Single high-dose liposomal amphotericin B plus B/F/TAF for AIDS-associated talaromycosis in China: a multicentre randomised controlled trial protocol. [PDF]

BMJ Open
Yan X, Meng X, Song W, Liu L, Chen J, Zhang R, Shen Y.   +6 more
europepmc   +1 more source

Pulmonary <i>Rhizopus arrhizus</i> infection treated with high-dose liposomal amphotericin B in a heart transplant recipient under ECMO: a case report. [PDF]

Front Med (Lausanne)
Jiang W, Zhai J, Li B, Ma J, Zhang S.
europepmc   +1 more source